SEC Comment Letter 0000000000-24-004293 to Bioceres Crop Solutions Corp. (BIOX) (CIK 0001769484) (BIOX)
Bioceres Crop Solutions Corp. (BIOX) (CIK 0001769484)
Date: April 19, 2024 · CIK: 0001769484 · Accession: 0000000000-24-004293
AI Filing Summary & Sentiment
File numbers found in text: 001-38836
Referenced dates: April 11, 2024
Letter
United States securities and exchange commission logo April 19, 2024 Enrique López Lecube Chief Financial Officer Bioceres Crop Solutions Corp. Ocampo 210 bis, Predio CCT, Rosario Province of Santa Fe, Argentina Re:Bioceres Crop Solutions Corp. Form 20-F for Fiscal Year Ended June 30, 2023 Response Letter Dated April 11, 2024 File No. 001-38836 Dear Enrique López Lecube: We have reviewed your [Month day, year] response to our comment letter and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our [Month day, year] letter. Form 20-F for Fiscal Year Ended June 30, 2023 9. Taxation, page F-58 1.We note your response to comment 6. It is unclear how the disclosures provided clearly explain how you calculated the income tax benefit (expense) by applying the tax rate in force in the respective countries. In this regard, you recognized earnings before income tax of $19.1 million for fiscal year 2023 but the beginning amount for the reconciliation is a benefit of $1.3 million. As previously requested, please disclose and provide us with the specific calculations that clearly show how the beginning amount for the reconciliation is calculated in accordance with IAS 12.81(c) for each period presented. Please also confirm that you will also provide a comprehensive explanation in MD&A for the material factors impacting the amount of income tax benefit (expense) recognized for each period presented including quantification of those factors.
FirstName LastNameEnrique López Lecube Comapany NameBioceres Crop Solutions Corp. April 19, 2024 Page 2 FirstName LastName Enrique López Lecube Bioceres Crop Solutions Corp. April 19, 2024 Page 2 Please contact Tracey Houser at 202-551-3736 or Terence O'Brien at 202-551-3355 if you have questions regarding comments on the financial statements and related matters. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
United States securities and exchange commission logo
April 19, 2024
Enrique López Lecube
Chief Financial Officer
Bioceres Crop Solutions Corp.
Ocampo 210 bis, Predio CCT, Rosario
Province of Santa Fe, Argentina
Re:Bioceres Crop Solutions Corp.
Form 20-F for Fiscal Year Ended June 30, 2023
Response Letter Dated April 11, 2024
File No. 001-38836
Dear Enrique López Lecube:
We have reviewed your [Month day, year] response to our comment letter and have the
following comment.
Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments. Unless
we note otherwise, any references to prior comments are to comments in our [Month day, year]
letter.
Form 20-F for Fiscal Year Ended June 30, 2023
9. Taxation, page F-58
1.We note your response to comment 6. It is unclear how the disclosures provided clearly
explain how you calculated the income tax benefit (expense) by applying the tax rate in
force in the respective countries. In this regard, you recognized earnings before income
tax of $19.1 million for fiscal year 2023 but the beginning amount for the reconciliation is
a benefit of $1.3 million. As previously requested, please disclose and provide us with the
specific calculations that clearly show how the beginning amount for the reconciliation is
calculated in accordance with IAS 12.81(c) for each period presented. Please also confirm
that you will also provide a comprehensive explanation in MD&A for the material factors
impacting the amount of income tax benefit (expense) recognized for each period
presented including quantification of those factors.
FirstName LastNameEnrique López Lecube
Comapany NameBioceres Crop Solutions Corp.
April 19, 2024 Page 2
FirstName LastName
Enrique López Lecube
Bioceres Crop Solutions Corp.
April 19, 2024
Page 2
Please contact Tracey Houser at 202-551-3736 or Terence O'Brien at 202-551-3355 if
you have questions regarding comments on the financial statements and related matters.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services